Biotech

All Articles

ReNeuron leaving AIM substitution after missing out on fundraising target

.ReNeuron has joined the long listing of biotechs to leave London's purpose stock market. The stalk ...

MBX apply for IPO to take challenger to Ascendis in to phase 3

.MBX Biosciences has actually contributed to the current outbreak of IPO filings. The biotech, which...

FDA grows probe into Lykos' MDMA tests: WSJ

.For Lykos Therapies and the firm's potential MDMA-assisted treatment for trauma (PTSD), the favorit...

Gene editor Tome giving up 131 laborers

.Only days after gene editor Tome Biosciences announced hidden functional cuts, a clearer image is a...

Repare lays off 25% of personnel as biotech standstills preclinical R&ampD

.Repare Therapeutics is actually laying off a quarter of its own workforce as the oncology biotech d...

J &amp J declare FDA approval of $6.5 B autoimmune medicine

.Johnson &amp Johnson has actually gotten one more step toward understanding a profit on its $6.5 bi...

Gain's stage 1 succeed paves means to show Parkinson's medicine's worth

.Increase Therapies has actually set its direct verifying the performance of its own Parkinson's ail...

Actinogen documents brand-new phase 2 data to save depression medication

.Actinogen Medical's chances-- as well as stock rate-- have recoiled somewhat from earlier this mont...

Pfizer and Flagship include Ratio to multibillion-dollar equation

.Crown Jewel Pioneering as well as Pfizer have added Quotient right into their 10-program relationsh...

Bayer markers $547M treaty to drive limits of noncoding RNA

.Bayer execs were interested to anxiety to Brutal this summer season that the German pharma giant's ...